EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line



Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line



Cancer Research 47(8): 2129-2135



Platelet aggregating activity of the NCG human neuroblastoma cell line was compared with that of the HL-60 human promyelocytic leukemia cell line. NCG, in intact cell suspensions and ultracentrifuged pellets, induced platelet aggregation most significantly in heparinized platelet rich plasma (PRP) containing 2.5 units/ml of heparin, but not in the presence of higher concentrations of heparin or 5 mM ethylenediamine-tetraacetate or in citrated PRP. NCG induced platelet aggregation was also inhibited by hirudin or (2R,4R)-4-methyl-1-[N2-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfon yl)-L- arginyl]-2-piperidinecarboxylic acid (MD 805) in the same manner as that of tissue thromboplastin induced platelet aggregation. HL-60 cells did not induce platelet aggregation in our heparinized PRP assay systems; however, after treatment with neuraminidase HL-60 cells became active in aggregating platelets in either heparinized or citrated PRP. NCG demonstrated high procoagulant activity by either intact cell suspensions or ultracentrifuged pellets. The procoagulant activity of NCG was reduced in Factor VII deficient human plasma as it was in the results obtained by tissue thromboplastin. These results suggest that NCG induces platelet aggregation via thrombin generated through procoagulant activity which is shed in association with microvesicles demonstrated in the ultracentrifuged pellets. This type of platelet aggregating activity found in NCG is significantly different from that of HL-60.

(PDF 0-2 workdays service: $29.90)

Accession: 006133967

Download citation: RISBibTeXText

PMID: 3829002



Related references

The influence of thrombin on the platelet-aggregating activity of human factor VIII. A study with insolubilized thrombin. Thrombosis and Haemostasis 42(3): 832-837, 1979

Platelet-aggregating activities of metastasizing tumor cells. IV. Effects of cell surface modification on thrombin generation, platelet aggregation and subsequent lung colonization. Invasion & Metastasis 6(1): 58-68, 1986

Regulatory Effect of Cell Density on the Platelet-aggregating Activity of Human Melanoma Cell Line. Platelets 6(4): 204-208, 1995

Inhibitory regulatory protein of adenylate cyclase mediated inhibition of human platelet and neuroblastoma glioma hybrid cell adenylate cyclase ec 4611 by thrombin. 1985

Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide. Cancer Research 41(11 Pt 1): 4535-4539, 1981

Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor: dansylarginine N-(3-ethyl-1, 5-pentanediyl)amide. Progress in Clinical and Biological Research 89: 479-502, 1982

Hemodynamic changes of adp atp and thrombin in relation to their platelet aggregating activity. Scandinavian Journal of Clinical & Laboratory Investigation 27(3): 213-219, 1971

Requirement for thrombin receptor occupancy during platelet secretion under aggregating and non-aggregating conditions. Thrombosis and Haemostasis 58(4): 1053-1059, 1987

Inhibition of the platelet aggregating activity of 2 human adeno carcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor dansyl arginine n 3 ethyl 1 5 pentanediylamide. Cancer Research 41(11 PART 1): 4535-4539, 1981

Platelet aggregating activities of metastasizing tumor cells 3 platelet aggregation as resulting from thrombin generation by tumor cells. 1985

Platelet-aggregating activities of metastasizing tumor cells. III. Platelet aggregation as resulting from thrombin generation by tumor cells. Invasion & Metastasis 5(2): 96-105, 1985

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Journal of Clinical Investigation 98(3): 863-874, 1996

Thrombin like platelet aggregating factor activity in plasma of thrombocytopenic purpura patients. Clinical Research 28(2): 320A, 1980

Inhibition by endothelial cells of platelet aggregating activity of thrombin role of thrombomodulin. Thrombosis Research 50(5): 647-656, 1988